[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

In Vitro Lung Model Market by Type (2D, 3D (In-house, Commercial)), Application (Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, Regenerative Medicine) - Global Forecasts to 2023

April 2018 | 100 pages | ID: ID59FBAC2B5EN
MarketsandMarkets

US$ 3,672.50 US$ 5,650.00 -35 %
Offer valid until December 31, 2024!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
“The global lung in vitro models market is projected to grow at a CAGR of 17.5%.”

The lung in vitro models market is expected to reach USD 427.4 million by 2023 from an estimated USD 190.5 million in 2018, at a CAGR of 17.5%. Focus on developing alternatives for animal testing models, advancements in 3D cell culture technology, and the development of new 3D in vitro models are factors driving the growth of this market. However, the dearth of skilled professionals is expected to challenge market growth during the forecast period.

“The 3D models segment is expected to grow at the highest CAGR during the forecast period.”

The lung in vitro models market is segmented into 2D cell models and 3D cell models. 3D cell models are further segmented into in-house 3D models and commercialized 3D models (ready-to-use). The 3D cell models segment is projected to grow at the fastest rate during the forecast period owing to the rising need for efficient lung in vitro models that mimic in vivo physiology.

“The drug discovery and toxicology applications of 3D lung in vitro models to grow at the highest rate during the forecast period

Based on application, the market is segmented applications of 2D models and 3D models. Applications of 2D models include drug discovery and toxicology, 3D model development, and basic research and the applications of 3D models include drug discovery and toxicology, physiological research, and stem cell research & regenerative medicine. The drug discovery and toxicology segment of 3D models are also expected grow at the highest CAGR in 2018.

“APAC to witness the highest growth during the forecast period.”

The APAC region is expected to register the highest CAGR during the forecast period. A growing economy, increasing healthcare investments which lead to increased research activities and in drug discovery, improving public health awareness of lung diseases, and increased funding for lung research are key market drivers in Asia Pacific.

Break of primary participants was as mentioned below:
  • By Company Type – Tier 1–45%, Tier 2–34% and Tier 3–21%
  • By Designation – C-level–59%, Director Level–28%, Others–13%
  • By Region – North America–40%, Europe–32%, Asia Pacific–20%, RoW–8%
The major players in the lung in vitro models market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).

Research Coverage:

The report analyzes the lung in vitro models market and aims at estimating the market size and future growth potential of this market based on various aspects such as type, application, and region. The report also includes an in-depth market trend analysis for various regions across the globe and competitive analysis of the key players along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in-turn would help them, garner a greater market share. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights on the following pointers:
  • Market Penetration: Comprehensive information about the product portfolios offered by key players in the global lung in vitro models market. The report analyzes the global lung in vitro models market by equipment and software, application, end user, and region
  • Product and Service Innovation: Detailed insights on upcoming trends and new product and service launches in the global lung in vitro models market
  • Market Development: Comprehensive information about the lucrative emerging markets by type, application, and region
  • Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the global lung in vitro models market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products in the pipeline of leading players in the global markets
1 INTRODUCTION

1.1 MARKET DEFINITION
1.2 CURRENCY
1.3 LIMITATIONS
1.4 ASSUMPTIONS FOR THE STUDY
1.5 YEARS CONSIDERED FOR THE STUDY
1.6 SEGMENTATION

2 RESEARCH METHODOLOGY

2.1 RESEARCH DESIGN
2.2 PRIMARY RESEARCH
2.3 BOTTOM UP APPROACH
2.4 TOP DOWN APPROACH
2.5 MARKET BREAKDOWN

3 EXECUTIVE SUMMARY

4 MARKET DYNAMIC

4.1 MARKET OVERVIEW
4.2 DRIVERS
  4.2.1 GROWING FOCUS ON DEVELOPING ALTERNATIVES FOR ANIMAL TESTING MODELS
  4.2.2 TECHNOLOGICAL ADVANCEMENTS AND THE DEVELOPMENT OF NEW 3D IN VITRO MODELS
  4.2.3 SIGNIFICANT INCREASE IN RESEARCH FUNDING AND VENTURE CAPITAL INVESTMENTS
4.3 OPPORTUNITIES
  4.3.1 INCREASING NUMBER OF DRUG DISCOVERY ACTIVITIES
  4.3.2 APPLICATIONS IN REGENERATIVE MEDICINE, TISSUE ENGINEERING, AND ONCOLOGY RESEARCH
4.4 CHALLENGES
  4.4.1 DEARTH OF SKILLED PROFESSIONALS

5 IN VITRO LUNG MODEL MARKET, BY TYPE

5.1 INTRODUCTION
5.2 2D CELL MODELS
5.3 3D CELL MODELS
  5.3.1 COMMERCIAL 3D CELL MODELS
  5.3.2 INHOUSE 3D CELL MODELS

6 IN VITRO LUNG MODEL MARKET, BY APPLICATION

6.1 INTRODUCTION
6.2 APPLICATIONS OF 2D MODELS
6.3 APPLICATIONS OF 3D MODELS

7 IN VITRO LUNG MODEL MARKET, BY REGION

7.1 INTRODUCTION
7.2 NORTH AMERICA
7.3 EUROPE
7.4 APAC
7.5 ROW

8 COMPETITIVE LANDSCAPE

8.1 MARKET OVERVIEW
8.2 MARKET EVOLUTION FRAMEWORK
8.3 MARKET RANKING ANALYSIS
8.4 COMPETETIVE SITUATIONS AND TRENDS
  8.4.1 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
  8.4.2 PRODUCT LAUNCHES AND UPGRADES
  8.4.3 EXPANSIONS

9 COMPANY PROFILES

9.1 ATCC
9.2 LONZA
9.3 EPITHELIX
9.4 MATTEK
9.5 EMULATE
9.6 TISSUSE
9.7 MIMETAS
9.8 INSPHERO
9.9 CN BIO INNOVATIONS

LIST OF TABLES

Table 1 LUNG IN VITRO MODELS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 2 LUNG IN VITRO MODELS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 3 2D LUNG IN VITRO MODELS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 4 3D LUNG IN VITRO MODELS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 5 3D LUNG IN VITRO MODELS MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 6 Commercialized 3D LUNG IN VITRO MODELS MARKET, BY Application, 2016–2023 (USD MILLION)
Table 7 Commercialized 3D LUNG IN VITRO MODELS MARKET, BY Region, 2016–2023 (USD MILLION)
Table 8 In-house 3D LUNG IN VITRO MODELS MARKET, By Application, 2016–2023 (USD MILLION)
Table 9 In-house 3D LUNG IN VITRO MODELS MARKET, By Region, 2016–2023 (USD MILLION)
Table 10 2D LUNG IN VITRO MODELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 11 DRUG DISCOVERY & TOXICOLOGY MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 12 3D MODEL DEVELOPMENT MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 13 'BASIC RESEARCH MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 14 '3D LUNG IN VITRO MODELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 15 'DRUG DISCOVERY & TOXICOLOGY MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 16 'PHYSIOLOGICAL RESEARCH MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 17 'STEM CELL & REGENERATIVE MEDICINE MARKET, BY REGION, 2016–2023 (USD MILLION)
Table 18 LUNG IN VITRO MODELS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION)
Table 19 'NORTH AMERICA: LUNG IN VITRO MODELS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 20 NORTH AMERICA: 2D LUNG IN VITRO MODELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 21 'NORTH AMERICA: 3D LUNG IN VITRO MODELS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 22 'NORTH AMERICA: Commercialized 3D LUNG IN VITRO MODELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 23 'NORTH AMERICA: In-house 3D LUNG IN VITRO MODELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 24 'NORTH AMERICA: 3D LUNG IN VITRO MODELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 25 'EUROPE: LUNG IN VITRO MODELS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 26 'EUROPE: 2D LUNG IN VITRO MODELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 27 'EUROPE: 3D LUNG IN VITRO MODELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 28 'Europe: Commercialized 3D LUNG IN VITRO MODELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 29 'EUROPE: IN-HOUSE 3D LUNG IN VITRO MODELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 30 'Europe: 3D LUNG IN VITRO MODELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 31 'ASIA PACIFIC: LUNG IN VITRO MODELS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 32 'ASIA PACIFIC: 2D LUNG IN VITRO MODELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 33 'ASIA PACIFIC: 3D LUNG IN VITRO MODELS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 34 'ASIA PACIFIC: COMMERCIALIZED 3D LUNG IN VITRO MODELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 35 'ASIA PACIFIC: IN-HOUSE 3D LUNG IN VITRO MODELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 36 'ASIA PACIFIC: 3D LUNG IN VITRO MODELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 37 'RoW: LUNG IN VITRO MODELS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 38 'RoW: 2D LUNG IN VITRO MODELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 39 'RoW: 3D LUNG IN VITRO MODELS MARKET, BY TYPE, 2016–2023 (USD MILLION)
Table 40 'RoW: COMMERCIALIZED 3D LUNG IN VITRO MODELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 41 'RoW: IN-HOUSE 3D LUNG IN VITRO MODELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
Table 42 'RoW: 3D LUNG IN VITRO MODELS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)


More Publications